Brett Haumann
2020
Compensation breakdown
Non-Equity Incentive Plan | $213,589 |
---|---|
Salary | $572,569 |
Stock Awards | $1,903,200 |
Other | $53,267 |
Total | $2,742,625 |
Haumann received $1.9M in stock awards, accounting for 69% of the total pay in 2020.
Haumann also received $213.6K in non-equity incentive plan, $572.6K in salary and $53.3K in other compensation.
Rankings
In 2020, Brett Haumann's compensation ranked 4,203rd out of 13,090 executives tracked by ExecPay. In other words, Haumann earned more than 67.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,203 out of 13,090 | 68th |
Division Manufacturing | 1,700 out of 5,624 | 70th |
Major group Chemicals And Allied Products | 657 out of 2,257 | 71st |
Industry group Drugs | 562 out of 1,957 | 71st |
Industry Pharmaceutical Preparations | 428 out of 1,462 | 71st |
Pay ratio
Brett Haumann's Pay | $2,742,625 |
---|---|
Median Employee's Pay | $269,883 |
Pay Ratio | 10to 1 |
In 2020, the annual total compensation of Brett Haumann was $2,742,625.
The annual total compensation of the median employee at Theravance Biopharma was $269,883.
The ratio of Brett Haumann's pay to the pay of median employee was therefore 10 to one.
Haumann's colleagues
We found four more compensation records of executives who worked with Brett Haumann at Theravance Biopharma in 2020.
News
March 22, 2021
March 24, 2020
March 20, 2019